FDA Inspection 939398 — Actelion Pharmaceuticals Ltd.

Actelion Pharmaceuticals Ltd. — FEI 3002995923

The FDA completed an inspection of Actelion Pharmaceuticals Ltd. on May 22, 2015 in Allschwil. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 22, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Allschwil (Switzerland)

Additional Details

Sponsor, Contract Research Organization